1. Home
  2. TLSA vs KNDI Comparison

TLSA vs KNDI Comparison

Compare TLSA & KNDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSA
  • KNDI
  • Stock Information
  • Founded
  • TLSA 2013
  • KNDI 2002
  • Country
  • TLSA United Kingdom
  • KNDI China
  • Employees
  • TLSA N/A
  • KNDI N/A
  • Industry
  • TLSA Biotechnology: Pharmaceutical Preparations
  • KNDI Auto Manufacturing
  • Sector
  • TLSA Health Care
  • KNDI Consumer Discretionary
  • Exchange
  • TLSA Nasdaq
  • KNDI Nasdaq
  • Market Cap
  • TLSA 87.8M
  • KNDI 91.2M
  • IPO Year
  • TLSA 2000
  • KNDI N/A
  • Fundamental
  • Price
  • TLSA $0.75
  • KNDI $1.17
  • Analyst Decision
  • TLSA
  • KNDI
  • Analyst Count
  • TLSA 0
  • KNDI 0
  • Target Price
  • TLSA N/A
  • KNDI N/A
  • AVG Volume (30 Days)
  • TLSA 1.1M
  • KNDI 115.2K
  • Earning Date
  • TLSA 02-18-2025
  • KNDI 03-13-2025
  • Dividend Yield
  • TLSA N/A
  • KNDI N/A
  • EPS Growth
  • TLSA N/A
  • KNDI N/A
  • EPS
  • TLSA N/A
  • KNDI N/A
  • Revenue
  • TLSA N/A
  • KNDI $118,127,232.00
  • Revenue This Year
  • TLSA N/A
  • KNDI N/A
  • Revenue Next Year
  • TLSA N/A
  • KNDI N/A
  • P/E Ratio
  • TLSA N/A
  • KNDI N/A
  • Revenue Growth
  • TLSA N/A
  • KNDI N/A
  • 52 Week Low
  • TLSA $0.41
  • KNDI $0.89
  • 52 Week High
  • TLSA $1.74
  • KNDI $2.98
  • Technical
  • Relative Strength Index (RSI)
  • TLSA 51.78
  • KNDI 56.77
  • Support Level
  • TLSA $0.65
  • KNDI $1.06
  • Resistance Level
  • TLSA $0.70
  • KNDI $1.12
  • Average True Range (ATR)
  • TLSA 0.05
  • KNDI 0.06
  • MACD
  • TLSA 0.01
  • KNDI 0.00
  • Stochastic Oscillator
  • TLSA 47.20
  • KNDI 53.85

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

About KNDI Kandi Technologies Group Inc

Kandi Technologies Group Inc is engaged in the development, production, and distribution of electric vehicle (EV) products, EV parts, and off-road vehicle products in the Chinese market. Other product offerings include all-terrain vehicles, go-karts, utility vehicles, battery packs, and other systems. It generates maximum revenue through off-road vehicles. The company generates the majority of its revenue from the United states along with other Countries, followed by China.

Share on Social Networks: